LAB57 ApS: Financial statements 2023
CVR: 41328932
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
LAB57 ApS (CVR 41328932) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,265 and a net result of DKK -6,451 compared with DKK -19,271 the year before. Equity in the 2023 report amounted to DKK 5,779. The solvency ratio was 6.3%.
- Gross Profit
- DKK -7,265
- Profit/Loss
- DKK -6,451
- Equity
- DKK 5,779
- Total Assets
- DKK 91,448
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -7 t. | -6 t. | 6 t. | - |
| 2022 | - | -23 t. | -19 t. | 12 t. | - |
| 2021 | - | -77 t. | -61 t. | 12 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
LAB57 ApS has published its annual report for 2022. Gross profit came to DKK -23,455, and the net result was DKK -19,271.
About LAB57 ApS
LAB57 ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2020. The company is registered under the industry Detailhandel med farmaceutiske produkter. The management consists of John Hyltoft. The board consists of Martin Thisted (chair) and John Hyltoft. The company is owned by KEY LEARNING A/S, John Hyltoft Holding ApS and Biogen Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -25,357 and a net result of DKK -25,453 compared with DKK -22,151 the year before. Equity in the 2025 report amounted to DKK -41,825.